LISATA THERAPEUTICS, INC. Deferred Tax Liabilities, Net, Current
LISATA THERAPEUTICS, INC. (LSTA) had Deferred Tax Liabilities, Net, Current of $655.13 thousand as of 2012-03-31, per its 10-Q filed 2012-05-11.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxLiabilitiesCurrent · last filed 2012-05-11
- 2012-03-31: Deferred Tax Liabilities, Net, Current $655.13K.
- 2011-12-31: Deferred Tax Liabilities, Net, Current $651.06K.
- 2011-09-30: Deferred Tax Liabilities, Net, Current $338.05K.
- 2011-06-30: Deferred Tax Liabilities, Net, Current $780.59K.
| Period end | Deferred Tax Liabilities, Net, Current |
|---|---|
| 2012-03-31 | $655.13K 10-Q · filed 2012-05-11 |
| 2011-12-31 | $651.06K 10-Q · filed 2012-05-11 |
| 2011-09-30 | $338.05K 10-Q · filed 2011-11-10 |
| 2011-06-30 | $780.59K 10-Q · filed 2011-08-12 |
| 2010-12-31 | $232.07K 10-K · filed 2012-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |